490 related articles for article (PubMed ID: 7513741)
1. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.
Schulman ES; Post TJ; Henson PM; Giclas PC
J Clin Invest; 1988 Mar; 81(3):918-23. PubMed ID: 2449462
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
Front Immunol; 2020; 11():615236. PubMed ID: 33597949
[TBL] [Abstract][Full Text] [Related]
4. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
Stimler-Gerard NP; Galli SJ
J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
[TBL] [Abstract][Full Text] [Related]
5. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.
Lowman MA; Benyon RC; Church MK
Br J Pharmacol; 1988 Sep; 95(1):121-30. PubMed ID: 2464382
[TBL] [Abstract][Full Text] [Related]
6. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
7. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
Jürgensen H; Behrendt H; Damerau B; Schmutzler W
Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
[TBL] [Abstract][Full Text] [Related]
8. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.
Ali H
Immunol Lett; 2010 Jan; 128(1):36-45. PubMed ID: 19895849
[TBL] [Abstract][Full Text] [Related]
10. Release of histamine from rat mast cells by the complement peptides C3a and C5a.
Johnson AR; Hugli TE; Müller-Eberhard HJ
Immunology; 1975 Jun; 28(6):1067-80. PubMed ID: 48505
[TBL] [Abstract][Full Text] [Related]
11. C5a, cutaneous mast cells, and inflammation: in vitro and in vivo studies in a murine model.
Lim HW; He D; Esquenazi-Behar S; Yancey KB; Soter NA
J Invest Dermatol; 1991 Aug; 97(2):305-11. PubMed ID: 1712820
[TBL] [Abstract][Full Text] [Related]
12. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
Basta M; Van Goor F; Luccioli S; Billings EM; Vortmeyer AO; Baranyi L; Szebeni J; Alving CR; Carroll MC; Berkower I; Stojilkovic SS; Metcalfe DD
Nat Med; 2003 Apr; 9(4):431-8. PubMed ID: 12612546
[TBL] [Abstract][Full Text] [Related]
13. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
14. C3a and C5a stimulate chemotaxis of human mast cells.
Hartmann K; Henz BM; Krüger-Krasagakes S; Köhl J; Burger R; Guhl S; Haase I; Lippert U; Zuberbier T
Blood; 1997 Apr; 89(8):2863-70. PubMed ID: 9108406
[TBL] [Abstract][Full Text] [Related]
15. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
Glovsky MM; Hugli TE; Ishizaka T; Lichtenstein LM; Erickson BW
J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
Brunner T; de Weck AL; Dahinden CA
J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
[TBL] [Abstract][Full Text] [Related]
17. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
18. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
Okayama Y; Benyon RC; Lowman MA; Church MK
Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
[TBL] [Abstract][Full Text] [Related]
20. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
Fukuoka Y; Hugli TE
J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
